ArticleBMC medicine2014

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.

Alice P S Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.